Navigation Links
Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Company's Inaccurate Description of Federal Court's Recent Certification Ruling
Date:7/6/2012

NEW YORK, July 6, 2012 /PRNewswire/ -- On MSLGroup's website, the Company claims that U.S. District Court Judge Andrew L. Carter's June 29, 2012 order granting conditional certification to the Company's women VPs and SVPs "was a procedural ruling only and not unexpected" and that the Court had "made no decision as to whether the case may proceed as a class action."  But in a statement issued today, Janette Wipper, a partner at Sanford Wittels & Heisler, LLP, the plaintiffs' lead counsel, strongly contested MSL's characterization of Judge Carter's certification decision. 

"MSLGroup's assertion on its website that the decision was 'expected' and simply 'procedural' differs from its lawyer's statements in Court," said Ms. Wipper. MSLGroup and Publicis Groupe consistently argued in their briefs that plaintiffs could not obtain conditional certification and that it would be 'unprecedented' for Judge Carter to order such relief. The very first line of the papers MSLGroup submitted to the Court on March 19, 2012, claims: 'Plaintiffs ask this Court to make an unprecedented ruling….'   The papers go on to state that 'federal courts have conditionally certified fewer than ten [Equal Pay Act] cases in nearly 50 years….' They certainly conveyed to the Court that ordering certification would be an unexpected result with a significant impact on the lawsuit." "Furthermore," noted Ms. Wipper, "MSLGroup hired an MIT-educated expert in hopes of refuting Plaintiffs' statistical evidence in support of conditional certification."

In his written opinion, Judge Carter decided that plaintiffs had provided "sufficient information that because of a common pay scale, [plaintiffs] were paid lower than the wages paid to men for the performance of substantially equal work."  The Judge relied on the findings of plaintiffs' statistical expert, Dr. Janice Madden, that female VPs and SVPs at Publicis Groupe were paid 8.5% to 11.2% less annually than male VPs and SVPs.  The judge also stated he was ordering notice of conditional certification to be sent to over a hundred of the Company's current and former female Vice Presidents and Senior Vice Presidents, so that they could join the class.

According to Steven Wittels, counsel for the plaintiffs and the class, MSL's erroneous description of Judge Carter's decision is no accident: "MSL is downplaying Judge Carter's extremely important ruling in an attempt to chill participation in the lawsuit from women whose rights to equal pay and equal job treatment have been violated."

The plaintiffs and the class are represented by Janette Wipper, Steven Wittels, Siham Nurhussein, and Deepika Bains of Sanford Wittels & Heisler, LLP.  In 2010, Sanford Wittels & Heisler settled the nation's largest gender discrimination class action, after winning a $253 million verdict from a federal jury in New York.

About Sanford Wittels & Heisler, LLP

Sanford Wittels & Heisler is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in employment discrimination, wage and hour, qui tam and consumer actions and complex corporate class action litigation and has represented thousands of individuals in major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters. In May 2010, the firm won the largest jury award in the U.S. in a gender discrimination employment class action when a jury returned a verdict of $253 million in compensatory and punitive damages against Novartis Pharmaceuticals Corporation.  In May 2012, SWH won final court approval to settle a wage and hour case on behalf of pharmaceutical representatives employed by Novartis Pharmaceuticals for $99 million.  For more information, contact Sanford Wittels & Heisler at (415) 795-2020.

For more information, contact Jamie Moss, newsPRos, 201-493-1027, 201-788-0142 (cell); or Jaime Baum, newsPRos, 847-502-3825.

 

 

 


'/>"/>
SOURCE Sanford Wittels & Heisler, LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKlines (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of Americas Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers Attorneys Say
2. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
3. Sanford Wittels & Heisler Files $100 Million Gender Discrimination Class Action In Southern District Of New York
4. Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device
5. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
6. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
7. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
8. eCardios CEO to Speak During "Act at the Speed of Opportunity" Event Presented by Comcast Business Class and Inc.
9. The Female Health Company Reports Second Quarter Operating Results
10. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
11. United Spinal To "Roll on Capitol Hill:" Voices Aim to Impact Federal Health Care Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Israel , May 4, 2016 ... BiondVax,s CEO, Dr. Ron Babecoff , will be attending ... York City . On Thursday, May 5, ... a conference presented by Joseph Gunner & Co, ... The BiondVax presentation that Dr. Babecoff will be using is ...
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... completion of an alternative public offering (APO). This was ... operating company, Valeritas, Inc. and a private placement of ... at $5.00 per share. Under the terms ... 3, 2016, Valeritas Holdings, Inc. will trade on the ...
Breaking Medicine Technology:
(Date:5/6/2016)... FL (PRWEB) , ... May 06, 2016 , ... ... will feature AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery ... the vision of becoming a leader in optimized drug discovery through innovative cellular ...
(Date:5/6/2016)... ... , ... Online HR/benefits platforms offer a range of benefits functions to employers ... health plans. “ The Rapid Emergence of Online Benefits Firms: Strategies for Health Plans ... will offer an accurate picture of online benefits today, and the possible risks and ...
(Date:5/6/2016)... ... 06, 2016 , ... Canadian author Mark Black is a speaker, author, and life ... around the world … with the help of his publisher Strategic Book Group and its ... in a hospital bed waiting for a miracle: He needed a heart and double-lung transplant. ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning ... and operated for over 35 years. Maintaining core values of exceptional customer service, quality ... and made them a leading name in San Diego plumbing, and other services including ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor of Military ... corporate training, and the National Military Family Association, a nonprofit that works to ... second full-tuition scholarship recipient of 2016. , “Being awarded this scholarship by ...
Breaking Medicine News(10 mins):